Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

417P - Lymph node (LN) retrieval as a high-risk factor in stage II and III colon cancer

Date

17 Sep 2020

Session

E-Poster Display

Topics

Tumour Site

Colon and Rectal Cancer

Presenters

Yitak Kim

Citation

Annals of Oncology (2020) 31 (suppl_4): S409-S461. 10.1016/annonc/annonc270

Authors

Y. Kim1, H.S. Kim2, S.J. Shin2, S. Beom2, N.K. Kim3, K.Y. Lee3, B.S. Min3, H. Hur3, M.S. Cho3, Y.D. Han3, S.Y. Yang3, W.S. Koom4, J.S. Chang4, T.I. Kim5, J.H. Cheon5, S.J. Park5, J.J. Park5, N.E. Seo6, J.S. Lim6, J.B. Ahn2

Author affiliations

  • 1 Department Of Medicine, Yonsei University College of Medicine, 120-752 - Seoul/KR
  • 2 Department Of Internal Medicine, Division Of Medical Oncology, Yonsei Cancer Center Yonsei University, 120-752 - Seoul/KR
  • 3 Department Of Surgery, Yonsei Cancer Center Yonsei University, 120-752 - Seoul/KR
  • 4 Department Of Radiation Oncology, Yonsei Cancer Center Yonsei University, 120-752 - Seoul/KR
  • 5 Department Of Internal Medicine, Institute Of Gastroenterology, Yonsei Cancer Center Yonsei University, 120-752 - Seoul/KR
  • 6 Department Of Radiology, Yonsei University College of Medicine, 120-752 - Seoul/KR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 417P

Background

In colon cancer, histology, lymphovascular or perineural invasion (LVI or PNI), bowel obstruction or perforation, <12 examined lymph nodes (LN), and resection margins are known to be high-risk features for recurrence. The number of retrieved LN has increased over time and requires a reassessment of its role. Our goal was to evaluate if LN retrieval is still valid for predicting the recurrence of colon cancer and refine the cut-off point.

Methods

Between 2005 and 2015, we reviewed 3,126 eligible patients with stage II and III colon cancer from the Yonsei Cancer Center (YCC) registry. Logistic regression analysis, Kaplan-Meier method, and Cox regression models were used to analyze 6-year overall survival (OS) and 3-year disease-free survival (DFS). Hazards and odds ratios with 95% confidence interval are reported. Optimal LN yield was evaluated by testing every cut-off from 3 to 165.

Results

In YCC, 5-year survival rate in stage III colon cancer has improved from 60.4% to 78.1% in the past 20 years, and LN retrieval was the only factor significantly associated with years (OR 1.28 [1.23-1.33], p < 0.001) after adjusting for sex, age, operated year, histology, T or N stage, tumor site, LVI or PNI, and margin. The median number of retrieved LNs was 22 (mean 24 ± 14, range 0-112) in stage II, 22 (mean 25 ± 15, range 2-165) in stage III colon cancers. LN count below 12 showed no significance with OS in stage II (HR 1.20, p = 0.335), in stage III (HR 1.34, p = 0.074), and also with DFS in stage II (HR 1.20, p = 0.300), in stage III (HR 1.12, p = 0.449). High histology grade (poorly differentiated adenocarcinoma, mucinous adenocarcinoma, signet ring cell carcinoma), T4 stage, N2 stage, LVI or PNI were all associated with worse OS in stage III (HR 1.55 [1.18-2.04], p = 0.00154; HR 2.65 [2.11-3.32], p < 0.001; HR 1.82 [1.46-2.27], p < 0.001; HR 1.38 [1.11-1.71], p = 0.00400, respectively). LN cut-off analysis in stage III showed that 19, 20, 21 were the only points significant with worse DFS (p = 0.0288, p = 0.0358, p = 0.0258, respectively).

Conclusions

Retrieving more than 12 LNs from surgery is crucial to prevent false negative nodal staging. However, our data suggest that LN count below 12 is not associated with survival in stage II and III colon cancer. Cut-off value of LN retrieval also needs to be re-evaluated.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.